December 2nd 2024
If granted, guselkumab will be approved to treat children ages 6 and younger with severe plaque psoriasis and children ages 5 and younger with juvenile psoriatic arthritis.
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Lipstick furrowing; facial redness; human or synthetic hair wigs?
October 1st 2004Lipstick movement into furrows on the upper and lower lips is a common problem encountered by mature women. It is caused by the loss of subcutaneous fat on the face and within the lips in combination with facial osteoporosis. The lip line of an adolescent girl protrudes from the face in a youthful pout, but with maturity, the lip line actually becomes flush with the face. This loss of volume results in the skin folding around the upper and lower lips, creating furrows into which lipstick can easily wick.
Tissue adhesive alternative to sutures, staples
October 1st 2004National report - Many dermatologists, especially pediatric dermatologists, have embraced 2-octyl cyanoacrylate tissue adhesive (Dermabond, Ethicon) as an alternative to using standard sutures and staples in selected patients. Dermabond has evolved, as a result of early complaints about dripping and smearing, to offer a new, higher-viscosity formulation. But it's unclear how effective the tissue adhesive is when skin tension exists.
New AD tx algorithm outlines severity-based approach to care
October 1st 2004A recently developed algorithm has been designed to provide a simple, stepwise approach to the management of atopic dermatitis (AD) based on disease severity, says its creator Lawrence F. Eichenfield, M.D., chief of pediatric and adolescent dermatology, Children's Hospital, San Diego, and clinical professor of pediatrics and medicine (dermatology), University of California San Diego School of Medicine.
New oral psoriasis agents show promise
September 1st 2004New York - While acitretin remains a common oral treatment for psoriasis, oral tazarotene (Allergan), fumaric acid esters (FAEs), and oral pimecrolimus can cut side effects ranging from alopecia to liver and kidney damage, according to a recent study.
Biologics promise efficacy, convenience but few studied for indication in children
September 1st 2004Charleston, S.C. - Biologic agents for pediatric dermatology offer the promise of being safer and much easier to use than traditional drugs, according to Elaine C. Siegfried, M.D., associate clinical professor of pediatrics and dermatology at St. Louis University School of Medicine, Mo.
Study aims to reduce risk of asthma by treating infant atopic dermatitis
September 1st 2004National report - A large, prospective, six-year clinical trial is well under way to investigate whether early, aggressive treatment of atopic dermatitis in infants can alter the future course of their skin disorder and the development of other manifestations of atopy, particularly asthma.
Dermatologists play important team role in care of pediatric transplant recipients
September 1st 2004Charleston, S.C. - Skin diseases are common among pediatric solid organ transplant recipients, and so dermatologists play an important role in the management of these children, said Maria C. Garzon, M.D., at the 2004 annual meeting of the Society for Pediatric Dermatology here.
Tacrolimus bests pimecrolimus for treatment of AD, study says
September 1st 2004Kona, Hawaii - Tacrolimus ointment is superior to pimecrolimus cream in treating atopic dermatitis, according to recent trial data reported by Alan Fleischer, M.D., during the 28th Annual Hawaii Dermatology Seminar here. Both calcineurin inhibitors have identical modes of action and identical metabolism, and bind to the same FKBP receptor. "But pimecrolimus has one-third the binding affinity of tacrolimus," he says.